Blastic Plasmacytoid Dendritic Cell Neoplasm with Leukemic Component

Journal Title: Turkish Journal of Hematology - Year 2019, Vol 36, Issue 3

Abstract

.

Authors and Affiliations

Maria Jimenez

Keywords

Related Articles

Dose Adjustment Helps Obtain Better Outcomes in Multiple Myeloma Patients with Bortezomib, Melphalan, and Prednisolone (VMP) Treatment

Objective: Multiple myeloma (MM) has a better survival outcome because of the development of drugs. However, equivalent outcomes cannot be expected from the same drug. Therefore, how the treatment schedule is managed is...

Varicella-Zoster Virus Infections in Pediatric Malignancy Patients: A Seven-Year Analysis

Primary varicella-zoster virus (VZV) infection is a benign self-limited disease. In this study, we review our experience in focusing on the outcome and treatment of VZV infection in pediatric malignancy patients. During...

Download PDF file
  • EP ID EP642891
  • DOI 10.4274/tjh.galenos.2019.2018.0363
  • Views 81
  • Downloads 0

How To Cite

Maria Jimenez (2019). Blastic Plasmacytoid Dendritic Cell Neoplasm with Leukemic Component. Turkish Journal of Hematology, 36(3), 201-202. https://europub.co.uk/articles/-A-642891